OXIG vs. IQE, NANO, FBT, DARK, SOPH, SCT, CCC, SXS, RSW, and NETW
Should you be buying Oxford Instruments stock or one of its competitors? The main competitors of Oxford Instruments include IQE (IQE), Nanoco Group (NANO), First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (FBT), Darktrace (DARK), Sophos Group plc (SOPH.L) (SOPH), Softcat (SCT), Computacenter (CCC), Spectris (SXS), Renishaw (RSW), and Network International (NETW). These companies are all part of the "computer and technology" sector.
Oxford Instruments (LON:OXIG) and IQE (LON:IQE) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, media sentiment, valuation, institutional ownership and community ranking.
Oxford Instruments has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500. Comparatively, IQE has a beta of 1.95, meaning that its share price is 95% more volatile than the S&P 500.
Oxford Instruments has higher revenue and earnings than IQE. IQE is trading at a lower price-to-earnings ratio than Oxford Instruments, indicating that it is currently the more affordable of the two stocks.
IQE received 52 more outperform votes than Oxford Instruments when rated by MarketBeat users. Likewise, 74.96% of users gave IQE an outperform vote while only 67.37% of users gave Oxford Instruments an outperform vote.
In the previous week, IQE had 12 more articles in the media than Oxford Instruments. MarketBeat recorded 12 mentions for IQE and 0 mentions for Oxford Instruments. IQE's average media sentiment score of 0.31 beat Oxford Instruments' score of 0.00 indicating that IQE is being referred to more favorably in the news media.
Oxford Instruments has a net margin of 10.78% compared to IQE's net margin of -25.49%. Oxford Instruments' return on equity of 14.29% beat IQE's return on equity.
Oxford Instruments currently has a consensus target price of GBX 2,648.33, suggesting a potential upside of 21.48%. IQE has a consensus target price of GBX 55, suggesting a potential upside of 187.36%. Given IQE's stronger consensus rating and higher possible upside, analysts clearly believe IQE is more favorable than Oxford Instruments.
71.8% of Oxford Instruments shares are owned by institutional investors. Comparatively, 65.9% of IQE shares are owned by institutional investors. 5.0% of Oxford Instruments shares are owned by insiders. Comparatively, 19.3% of IQE shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
Oxford Instruments beats IQE on 10 of the 18 factors compared between the two stocks.
Get Oxford Instruments News Delivered to You Automatically
Sign up to receive the latest news and ratings for OXIG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OXIG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Oxford Instruments Competitors List
Related Companies and Tools
Free OXIG Stock Alerts